VSee Health, Inc. Increase (Decrease) in Deferred Revenue
VSee Health, Inc. (VSEE) reported Increase (Decrease) in Deferred Revenue of $122.10 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-05-15
- VSee Health, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was $122.10K, a 65.98% decline year-over-year.
- VSee Health, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-03-31 was $358.86K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month |
|---|---|
| 2026-03-31 | $122.10K 10-Q · filed 2026-05-15 |
| 2025-03-31 | $358.86K 10-Q · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |